Provided by Javier Huarte
Javier Huarte is one of the country’s most experienced and active patent litigators with more than 21 years’ experience representing a wide range of pharmaceutical companies in complex disputes concerning generics and blockbuster drug patents.
He has an extensive knowledge of European patent law, regularly setting precedents in pan European pharma patent litigations.
He also works in patent matters and court cases relating to biologic innovative products and biosimilars, acting for clients including leading global drug companies, in some highly sophisticated cases.. He has attained many landmark victories in court cases involving blockbuster drugs such as Zocor® (simvastatin), Cipralex® (escitalopram), Viagra® (sildenafil), Lyrica® (pregabalin), Exelon® (rivastigmine), Yasminelle® (drospirenone), Seroquel® (quetiapine), Bonviva® (ibandronate), Tracleer® (bosentan), Exforge® (valsartan/amlodipine), Truvada® (tenofovir/emtricitabine), Inegy® (ezetimibe/simvastatin), Nexavar® (sorafenib) and many more.
Javier joined Grau & Angulo in 2003 and has been a partner since 2005.
He leads the firm’s team for advice and litigation on pharmaceutical patents. He has formed an excellent portfolio of clients and for over twenty years he has acted in some of the most groundbreaking pharmaceutical patent cases in Spain.
He is a Member of the Barcelona Bar Association and AIPPI.
Javier Huarte is often identified as a leading figure of patent litigation relating to generic drugs. Clients note his understanding of the pharmaceutical industry and say that "his knowledge and strategic vision beyond purely legal issues is remarkable."